SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Jul-24 4:48 PM View: | Annexon, Inc. (ANNX) | 15-Jul-24 | Sale | 1,104 | $6.03 | $6,657.12 | (1%) 87.57K to 86.47K | |
21-Feb-24 4:31 PM View: | Annexon, Inc. (ANNX) | 20-Feb-24 | Sale | 2,593 | $5.53 | $14,339.30 | (3%) 84.65K to 82.06K | |
21-Feb-24 4:31 PM View: | Annexon, Inc. (ANNX) | 16-Feb-24 | Grant | 39,000 | -- | -- | 85% 45.65K to 84.65K | |
14-Feb-24 7:54 PM View: | Annexon, Inc. (ANNX) | 12-Feb-24 | Sale | 1,809 | $5.54 | $10,021.90 | (4%) 47.46K to 45.65K | |
23-Jan-24 4:57 PM View: | Annexon, Inc. (ANNX) | 11-Jul-23 | Sale | 1,057 | $3.84 | $4,054.76 | (2%) 48.52K to 47.46K | |
21-Feb-23 5:26 PM View: | Annexon, Inc. (ANNX) | 16-Feb-23 | Grant | 18,975 | -- | -- | 64% 29.54K to 48.52K | |
15-Feb-23 6:59 PM View: | Annexon, Inc. (ANNX) | 14-Feb-23 | Sale | 166 | $6.30 | $1,046.30 | (< 1%) 29.71K to 29.54K | |
15-Feb-23 6:59 PM View: | Annexon, Inc. (ANNX) | 13-Feb-23 | Sale | 1,742 | $6.31 | $10,988.70 | (6%) 31.45K to 29.71K | |
13-Jul-22 6:48 PM View: | Annexon, Inc. (ANNX) | 11-Jul-22 | Grant | 9,375 | -- | -- | 65% 14.5K to 23.88K | |
15-Feb-22 4:36 PM View: | Annexon, Inc. (ANNX) | 11-Feb-22 | Grant | 12,500 | -- | -- | 625% 2.0K to 14.5K | |
15-Sep-21 6:35 PM View: | Annexon, Inc. (ANNX) | 13-Sep-21 | Option Exercise | 3,500 | $7.49 | $26,209.80 | 175% 2.0K to 5.5K | |
15-Sep-21 6:35 PM View: | Annexon, Inc. (ANNX) | 13-Sep-21 | Market Option Sale (Planned) | 3,500 | $20.01 | $70,033.60 | (64%) 5.5K to 2.0K | |
01-Jun-21 6:01 PM View: | Annexon, Inc. (ANNX) | 27-May-21 | Option Exercise | 3,500 | $7.49 | $26,209.80 | 175% 2.0K to 5.5K | |
01-Jun-21 6:01 PM View: | Annexon, Inc. (ANNX) | 27-May-21 | Market Option Sale (Planned) | 3,500 | $22.24 | $77,835.10 | (64%) 5.5K to 2.0K | |
25-Mar-21 7:31 PM View: | Annexon, Inc. (ANNX) | 23-Mar-21 | Option Exercise | 5,000 | $7.49 | $37,442.50 | 250% 2.0K to 7.0K | |
25-Mar-21 7:31 PM View: | Annexon, Inc. (ANNX) | 23-Mar-21 | Market Option Sale (Planned) | 5,000 | $28.44 | $142,176.00 | (71%) 7.0K to 2.0K | |
28-Jul-20 4:18 PM View: | Annexon, Inc. (ANNX) | 28-Jul-20 | Purchase | 2,000 | $17.00 | $34,000.00 | 100% 0 to 2.0K | |
03-May-19 7:17 PM View: | Chinook Therapeutics, Inc. (KDNY) | 01-May-19 | Option Exercise | 18,602 | $1.25 | $23,306.10 | 14% 135.16K to 153.76K | |
03-May-19 7:17 PM View: | Chinook Therapeutics, Inc. (KDNY) | 01-May-19 | Market Option Sale (Planned) | 18,602 | $4.20 | $78,135.80 | (12%) 153.76K to 135.16K | 18% |
10-Apr-19 7:09 PM View: | Chinook Therapeutics, Inc. (KDNY) | 08-Apr-19 | Option Exercise | 18,601 | $1.25 | $23,305.30 | 14% 135.16K to 153.76K | |
10-Apr-19 7:09 PM View: | Chinook Therapeutics, Inc. (KDNY) | 08-Apr-19 | Market Option Sale (Planned) | 18,601 | $4.07 | $75,775.10 | (12%) 153.76K to 135.16K | 15% |
14-Dec-18 4:19 PM View: | Chinook Therapeutics, Inc. (KDNY) | 12-Dec-18 | Market Sale | 1,035 | $2.93 | $3,034.62 | (< 1%) 136.19K to 135.16K | (17%) |
14-Sep-18 7:27 PM View: | Chinook Therapeutics, Inc. (KDNY) | 13-Sep-18 | Market Sale | 5,623 | $6.50 | $36,545.60 | (4%) 141.81K to 136.19K | 47% |
14-Sep-18 7:27 PM View: | Chinook Therapeutics, Inc. (KDNY) | 12-Sep-18 | Grant | 67,825 | -- | -- | 92% 73.99K to 141.81K | |
13-Dec-17 8:16 PM View: | Chinook Therapeutics, Inc. (KDNY) | 11-Dec-17 | Grant | 11,650 | -- | -- | 19% 62.34K to 73.99K | |
04-Dec-17 7:57 PM View: | Chinook Therapeutics, Inc. (KDNY) | 01-Dec-17 | Option Exercise | 6,600 | $0.82 | $5,412.00 | 11% 62.34K to 68.94K | |
04-Dec-17 7:57 PM View: | Chinook Therapeutics, Inc. (KDNY) | 01-Dec-17 | Market Option Sale (Planned) | 6,600 | $9.46 | $62,432.70 | (10%) 68.94K to 62.34K | 64% |
17-Nov-17 6:42 PM View: | Chinook Therapeutics, Inc. (KDNY) | 15-Nov-17 | Option Exercise | 6,600 | $0.82 | $5,412.00 | 11% 62.34K to 68.94K | |
17-Nov-17 6:42 PM View: | Chinook Therapeutics, Inc. (KDNY) | 15-Nov-17 | Market Option Sale (Planned) | 6,600 | $8.95 | $59,070.00 | (10%) 68.94K to 62.34K | 62% |
04-Oct-17 8:21 PM View: | Chinook Therapeutics, Inc. (KDNY) | 02-Oct-17 | Option Exercise | 6,600 | $0.82 | $5,412.00 | 11% 62.34K to 68.94K | |
04-Oct-17 8:21 PM View: | Chinook Therapeutics, Inc. (KDNY) | 02-Oct-17 | Market Option Sale (Planned) | 6,600 | $10.61 | $69,995.00 | (10%) 68.94K to 62.34K | 68% |
14-Sep-17 9:21 PM View: | Chinook Therapeutics, Inc. (KDNY) | 13-Sep-17 | Market Sale | 3,557 | $10.99 | $39,076.50 | (5%) 65.89K to 62.34K | 69% |
14-Sep-17 9:21 PM View: | Chinook Therapeutics, Inc. (KDNY) | 12-Sep-17 | Grant | 23,300 | -- | -- | 55% 42.59K to 65.89K | |
06-Sep-17 4:29 PM View: | Chinook Therapeutics, Inc. (KDNY) | 01-Sep-17 | Option Exercise | 6,600 | $0.82 | $5,412.00 | 15% 42.59K to 49.2K | |
06-Sep-17 4:29 PM View: | Chinook Therapeutics, Inc. (KDNY) | 01-Sep-17 | Market Option Sale (Planned) | 6,600 | $11.70 | $77,242.40 | (13%) 49.2K to 42.59K | 71% |
09-Aug-17 7:41 PM View: | Chinook Therapeutics, Inc. (KDNY) | 07-Aug-17 | Option Exercise | 6,600 | $0.82 | $5,412.00 | 15% 42.59K to 49.2K | |
09-Aug-17 7:41 PM View: | Chinook Therapeutics, Inc. (KDNY) | 07-Aug-17 | Market Option Sale (Planned) | 6,600 | $12.17 | $80,290.30 | (13%) 49.2K to 42.59K | 72% |
06-Jul-17 7:13 PM View: | Chinook Therapeutics, Inc. (KDNY) | 03-Jul-17 | Option Exercise | 12,000 | $0.82 | $9,840.00 | 28% 42.59K to 54.59K | |
06-Jul-17 7:13 PM View: | Chinook Therapeutics, Inc. (KDNY) | 03-Jul-17 | Market Option Sale (Planned) | 12,000 | $11.14 | $133,632.00 | (22%) 54.59K to 42.59K | 69% |
30-Jun-17 6:03 PM View: | Chinook Therapeutics, Inc. (KDNY) | 28-Jun-17 | Option Exercise | 12,000 | $0.82 | $9,840.00 | 28% 42.59K to 54.59K | |
30-Jun-17 6:03 PM View: | Chinook Therapeutics, Inc. (KDNY) | 28-Jun-17 | Market Option Sale (Planned) | 12,000 | $11.19 | $134,236.00 | (22%) 54.59K to 42.59K | 69% |
14-Nov-16 7:02 PM View: | Chinook Therapeutics, Inc. (KDNY) | 10-Nov-16 | Option Exercise | 10,910 | $0.82 | $8,946.20 | 26% 42.59K to 53.51K | |
14-Nov-16 7:02 PM View: | Chinook Therapeutics, Inc. (KDNY) | 10-Nov-16 | Market Option Sale (Planned) | 10,910 | $14.95 | $163,104.00 | (20%) 53.51K to 42.59K | 79% |
21-Sep-16 4:57 PM View: | Chinook Therapeutics, Inc. (KDNY) | 19-Sep-16 | Option Exercise | 5,455 | $0.82 | $4,473.10 | 13% 43.5K to 48.95K | |
21-Sep-16 4:57 PM View: | Chinook Therapeutics, Inc. (KDNY) | 19-Sep-16 | Market Option Sale (Planned) | 5,455 | $14.95 | $81,552.20 | (11%) 48.95K to 43.5K | 79% |
21-Sep-16 4:57 PM View: | Chinook Therapeutics, Inc. (KDNY) | 19-Sep-16 | Market Sale (Planned) | 905 | $14.95 | $13,529.80 | (2%) 43.5K to 42.59K | 79% |
14-Sep-16 4:18 PM View: | Chinook Therapeutics, Inc. (KDNY) | 12-Sep-16 | Grant | 37,300 | -- | -- | 602% 6.2K to 43.5K | |
06-Jan-16 6:13 PM View: | Chinook Therapeutics, Inc. (KDNY) | 06-Jan-16 | Option Exercise | 5,242 | $0.82 | $4,298.44 | 85% 6.2K to 11.44K | |
06-Jan-16 6:13 PM View: | Chinook Therapeutics, Inc. (KDNY) | 06-Jan-16 | Market Option Sale (Planned) | 5,242 | $25.71 | $134,765.00 | (46%) 11.44K to 6.2K | 88% |
29-Dec-15 6:11 PM View: | Chinook Therapeutics, Inc. (KDNY) | 29-Dec-15 | Option Exercise | 4,200 | $0.82 | $3,444.00 | 210% 2.0K to 6.2K |